MONEY

Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 23, 2024 - 20:00
Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
Read More

Tags:

Previous Article

VitalHub Announces Strategic Hire to Accelerate Corporate Growth

Next Article

Intel, Constellation Energy and Trump Media rise premarket; GM and Nike fall

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Displaced Gazan mothers struggle to care for their newborns

Displaced Gazan mothers struggle to care for their newb...

Tomas Kauer - Mode... Oct 7, 2024

Axonics CFO sells over $205k in company stock

Axonics CFO sells over $205k in company stock

Tomas Kauer - Mode... Oct 4, 2024

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Customers Bancorp, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - CUBI

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Customer...

Tomas Kauer - Mode... Dec 19, 2024